Mark Samuels, chairman and chief executive officer of SpectRx, said Monday that he would retire this year.

However, Samuels will not leave until a replacement is found. He also plans to remain a member of the firm’s board.

SpectRx is focused on development of non-invasive cancer detection technology.

Samuels is a co-founder of the company.